MEDICINES CO's ticker is MDCO and the CUSIP is 584688105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,596,000 | +719.3% | 54,104 | +266.3% | 0.01% | +400.0% |
| Q2 2017 | $561,000 | +44.2% | 14,772 | +85.7% | 0.00% | 0.0% |
| Q1 2017 | $389,000 | -33.7% | 7,955 | -48.8% | 0.00% | 0.0% |
| Q3 2016 | $587,000 | -29.8% | 15,546 | -37.5% | 0.00% | 0.0% |
| Q2 2016 | $836,000 | -0.7% | 24,868 | -6.2% | 0.00% | -50.0% |
| Q1 2016 | $842,000 | -13.9% | 26,499 | +1.2% | 0.00% | 0.0% |
| Q4 2015 | $978,000 | +158.0% | 26,196 | +162.4% | 0.00% | +100.0% |
| Q3 2015 | $379,000 | +4.7% | 9,985 | -38.5% | 0.00% | 0.0% |
| Q3 2014 | $362,000 | -22.8% | 16,235 | +0.6% | 0.00% | 0.0% |
| Q2 2014 | $469,000 | -21.6% | 16,135 | -23.3% | 0.00% | -50.0% |
| Q1 2014 | $598,000 | -50.9% | 21,035 | -33.2% | 0.00% | -50.0% |
| Q4 2013 | $1,217,000 | +100.5% | 31,507 | +74.0% | 0.00% | +100.0% |
| Q3 2013 | $607,000 | -72.9% | 18,107 | -75.1% | 0.00% | -75.0% |
| Q2 2013 | $2,236,000 | -19.6% | 72,707 | -37.3% | 0.01% | -33.3% |
| Q4 2012 | $2,781,000 | – | 116,006 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,752,000 | $58,919,000 | 16.72% |
| Antipodean Advisors LLC | 467,223 | $15,713,000 | 9.50% |
| BRIDGER MANAGEMENT, LLC | 2,412,501 | $81,132,000 | 5.24% |
| Signpost Capital Advisors, LP | 219,998 | $7,399,000 | 3.90% |
| Camber Capital Management LP | 2,000,000 | $67,260,000 | 3.25% |
| Partner Investment Management, L.P. | 50,808 | $1,709,000 | 2.80% |
| ASHFORD CAPITAL MANAGEMENT INC | 368,392 | $12,389,000 | 2.77% |
| PFM Health Sciences, LP | 2,618,754 | $88,069,000 | 2.66% |
| IMA Wealth, Inc. | 99,569 | $3,300,000 | 2.07% |
| First Light Asset Management, LLC | 125,889 | $4,234,000 | 1.96% |